Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2018-02-24
Buyer: Queen's University Belfast
Country: UK
Contract type: Supplies
CPV classification: 30236200 | 33000000 | 33100000 | 33110000: Imaging equipment for medical use | 38000000

Technical requirements: Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment, the technical requirements of these instruments include:
Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of automated nucleic acid extraction equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome.
Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes provides of high throughout next-generation sequencing equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome.
Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of Nucleic Acid Fragment Analysis equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome.
Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of liquid handler equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome.
Economic operators wishing to participate in this market engagement exercise are required to register their company details on In-Tend, the QUB's electronic tendering site https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
Once registered, Economic Operators should log on to In-Tend and select Tenders current: QUB/1709/18 supply, delivery, installation, commissioning and maintenance of genomic instruments — Market engagement. Economic operators are required to express an interest in this specific exercise before being able to access the document. Responses are required to be submitted no later than 4:00 pm on 28.3.2018.